Outlook Therapeutics
OTLK
#9571
Rank
ยฃ27.74 M
Marketcap
ยฃ1.17
Share price
3.52%
Change (1 day)
-83.33%
Change (1 year)

Earnings for Outlook Therapeutics (OTLK)

Earnings in 2024 (TTM): -ยฃ74.85 Million

According to Outlook Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ41.09 Million, an increase over its 2022 earnings that were of -ยฃ56.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Outlook Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ74.85 Million82.17%
2023 -ยฃ41.09 Million-26.7%
2022 -ยฃ56.05 Million32.13%
2021 -ยฃ42.42 Million46.21%
2020 -ยฃ29.02 Million-18.82%
2019 -ยฃ35.74 Million16.62%
2018 -ยฃ30.65 Million57.88%
2017 -ยฃ19.41 Million-56.17%
2016 -ยฃ44.29 Million-9.26%
2015 -ยฃ48.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ91.32 Million 21.71% Jersey
-ยฃ0.21 Billion 179.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ10.01 Million-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ58.29 Million-22.31%๐Ÿ‡ฌ๐Ÿ‡ง UK